Lantheus Holdings, Inc. (LNTH) stock
LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3012% above fair value
$101.80+0.08 (+0.08%)
Close on Nov 17, 2026Market cap $6.64BP/E 24.6Yield –
Lantheus operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Lantheus's operating cash flow for the twelve months ending Jun 30, 2026 was $412.80M, down 21.7% year over year. For fiscal 2025 it was $390.14M, down 28.4% from the year before. Over ten years it grew 33.5% a year on average. The highest annual figure on record is $544.75M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $390.14M | -28.4% |
| FY2024 | Dec 31, 2024 | $544.75M | +78.5% |
| FY2023 | Dec 31, 2023 | $305.26M | +8.3% |
| FY2022 | Dec 31, 2022 | $281.78M | +422.6% |
| FY2021 | Dec 31, 2021 | $53.92M | +228.8% |
| FY2020 | Dec 31, 2020 | $16.40M | -79.6% |
| FY2019 | Dec 31, 2019 | $80.38M | +31.4% |
| FY2018 | Dec 31, 2018 | $61.19M | +11.7% |
| FY2017 | Dec 31, 2017 | $54.78M | +10.3% |
| FY2016 | Dec 31, 2016 | $49.64M | +128.1% |
| FY2015 | Dec 31, 2015 | $21.76M | +87.8% |
| FY2014 | Dec 31, 2014 | $11.59M | – |
| FY2013 | Dec 31, 2013 | -$15.57M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $92.20M | +5.9% |
| Q1 FY2026 | Mar 31, 2026 | $125.13M | +16.3% |
| Q4 FY2025 | Dec 31, 2025 | $90.18M | -42.8% |
| Q3 FY2025 | Sep 30, 2025 | $105.29M | -39.9% |
| Q2 FY2025 | Jun 30, 2025 | $87.11M | +2.8% |
| Q1 FY2025 | Mar 31, 2025 | $107.56M | -15.5% |
| Q4 FY2024 | Dec 31, 2024 | $157.73M | +40.5% |
| Q3 FY2024 | Sep 30, 2024 | $175.06M | +50.0% |
| Q2 FY2024 | Jun 30, 2024 | $84.72M | – |
| Q1 FY2024 | Mar 31, 2024 | $127.24M | +17.3% |
| Q4 FY2023 | Dec 31, 2023 | $112.29M | +6.6% |
| Q3 FY2023 | Sep 30, 2023 | $116.74M | +24.8% |
| Q2 FY2023 | Jun 30, 2023 | -$32.27M | -144.4% |
| Q1 FY2023 | Mar 31, 2023 | $108.50M | +957.1% |
| Q4 FY2022 | Dec 31, 2022 | $105.35M | +658.5% |
| Q3 FY2022 | Sep 30, 2022 | $93.57M | +2055.9% |
| Q2 FY2022 | Jun 30, 2022 | $72.60M | +180.6% |
| Q1 FY2022 | Mar 31, 2022 | $10.26M | +4.5% |
| Q4 FY2021 | Dec 31, 2021 | $13.89M | +2340.9% |
| Q3 FY2021 | Sep 30, 2021 | $4.34M | -49.4% |
| Q2 FY2021 | Jun 30, 2021 | $25.87M | – |
| Q1 FY2021 | Mar 31, 2021 | $9.82M | +4.4% |
| Q4 FY2020 | Dec 31, 2020 | $569.00K | -97.5% |
| Q3 FY2020 | Sep 30, 2020 | $8.58M | -67.6% |
| Q2 FY2020 | Jun 30, 2020 | -$2.16M | -110.2% |
| Q1 FY2020 | Mar 31, 2020 | $9.41M | -10.1% |
| Q4 FY2019 | Dec 31, 2019 | $22.42M | +29.6% |
| Q3 FY2019 | Sep 30, 2019 | $26.44M | +8.9% |
| Q2 FY2019 | Jun 30, 2019 | $21.05M | +3.8% |
| Q1 FY2019 | Mar 31, 2019 | $10.47M | – |
| Q4 FY2018 | Dec 31, 2018 | $17.31M | +32.2% |
| Q3 FY2018 | Sep 30, 2018 | $24.28M | +55.6% |
| Q2 FY2018 | Jun 30, 2018 | $20.28M | -1.4% |
| Q1 FY2018 | Mar 31, 2018 | -$666.00K | -112.1% |
| Q4 FY2017 | Dec 31, 2017 | $13.09M | +2.4% |
| Q3 FY2017 | Sep 30, 2017 | $15.60M | +1.0% |
| Q2 FY2017 | Jun 30, 2017 | $20.57M | – |
| Q1 FY2017 | Mar 31, 2017 | $5.52M | – |
| Q4 FY2016 | Dec 31, 2016 | $12.78M | – |
| Q3 FY2016 | Sep 30, 2016 | $15.45M | – |
See a number that looks wrong?